Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bayer identifies novel thyroid hormone-like compounds with utility in lipoprotein disorders

Nov. 19, 2002

Modulators of estrogen receptors prepared and tested at GSK

Nov. 19, 2002

COPD and severe burns, two potential new indications for oxandrolone

Nov. 18, 2002

Oprelvekin reported to increase platelet counts in hepatitis C patients

Nov. 14, 2002

Orally active 5-HT2C receptor agonist synthesized at Vernalis as potential antiobesity agent

Nov. 14, 2002

Cholesterol-lowering efficacy of SMP-500, a novel ACAT inhibitor, in hyperlipidemic hamsters

Nov. 14, 2002

Targeted Genetics presents promising preclinical data from hemophilia program

Nov. 13, 2002

Merck scientists study antidiabetic biguanide compounds

Nov. 13, 2002

Pfizer announces approval of Lipitor for use in children

Nov. 13, 2002

Novel AGE-breaking agents prepared and tested at Torrent

Nov. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...